Loading...
Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia
BACKGROUND AIMS: Several studies have demonstrated that the immunogenicity of chronic lymphocytic leukemia (CLL) cells can be increased by manipulation of the CD40/CD40-ligand (CD40L) pathway. Although immunologic, and perhaps clinical, benefits have been obtained with an autologous CLL tumor vaccin...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3687103/ https://ncbi.nlm.nih.gov/pubmed/21745159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14653249.2011.592523 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|